“…Until now, targeted microbubbles in renal disease have been primarily aimed at P-selectin in experimental models of renal inflammation after ischemia-reperfusion injury. Furthermore, renal upregulation of P-selectin expression has been described for several other kidney diseases including renal allograft dysfunction [90-92], glomerulonephritis[93-95], renal shock[96,97] and diabetic nephropathy [98,99], indicating that microbubbles targeted to P-selectin may be applied in these kidney diseases. However, the selective targeting of microbubbles to leukocyte anchoring molecules in kidney disease may be compromised when the kidney disease is accompanied by a state of systemic inflammation such as sepsis, reperfusion injury, atheriosclerosis and metabolic dysfunction.…”